AVEO PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 16120
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS345
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0306,008 METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENTSep 25, 15Oct 26, 17[A61K, C07K]
2017/0137,505 TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATORJun 19, 15May 18, 17[C07K]
2017/0137,506 TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATORJun 19, 15May 18, 17[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896730 Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatmentApr 25, 12Feb 20, 18[C12Q]
9879083 Anti-Notch3 antibodiesDec 19, 13Jan 30, 18[A61K, C12N, C07K]
9828635 Predicting tumor response to anti-ERBB3 antibodiesOct 05, 12Nov 28, 17[A61K, C12Q, G01N]
9725505 Methods of treatment using anti-GDF15 antibodiesSep 24, 15Aug 08, 17[A61K, C07K]
9598498 Anti-ErbB3 antibodiesJan 04, 16Mar 21, 17[A61K, C07K]
9345788 Reconstituted human breast tumor modelJun 28, 05May 24, 16[A61K, A01K]
9228021 Anti-ErbB3 antibodiesJun 17, 13Jan 05, 16[A61K, C12P, C07K]
9175076 Anti-GDF15 antibodiesDec 20, 13Nov 03, 15[A61K, C12N, C07K]
9096664 Nucleic acid encoding hepatocyte growth factor (HGF) binding proteinsOct 02, 13Aug 04, 15[C07H, A61K, C12N, C07K]
8829164 Anti-ron antibodiesNov 01, 13Sep 09, 14[C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0285,817 Method for treating and identifying lung cancer patients likely to benefit from EGFR inhibitor and a monoclonal antibody HGF inhibitor combination therapyAbandonedApr 03, 15Oct 08, 15[A61K, G01N, G06F]
2014/0178,934 HEPATOCYTE GROWTH FACTOR (HGF) BINDING PROTEINSAbandonedSep 27, 13Jun 26, 14[C07K]
2014/0045,715 TIVOZANIB RESPONSE PREDICTIONAbandonedAug 05, 13Feb 13, 14[C12Q, G01N]
8603478 Anti-RON antibodiesExpiredJul 06, 11Dec 10, 13[A61K]
8575318 Hepatocyte growth factor (HGF) binding proteinsExpiredAug 20, 12Nov 05, 13[C07K]
2013/0288,305 ANTI-FGFR2 ANTIBODIESAbandonedJun 05, 13Oct 31, 13[C07K]
8481688 Anti-FGFR2 antibodiesExpiredMay 11, 11Jul 09, 13[C07K]
2013/0165,337 IDENTIFICATION OF MULTIGENE BIOMARKERSAbandonedNov 05, 12Jun 27, 13[C40B]
2013/0165,343 IDENTIFICATION OF MULTIGENE BIOMARKERSAbandonedFeb 25, 13Jun 27, 13[C12Q]
2012/0252,829 TIVOZANIB AND CAPECITABINE COMBINATION THERAPYAbandonedMar 30, 12Oct 04, 12[A61K, A61P]
8268315 English Title Not AvailableExpiredMar 18, 11Sep 18, 12[A61K]
2012/0231,478 TIVOZANIB RESPONSE PREDICTIONAbandonedJun 03, 10Sep 13, 12[G01N]
8187601 Fibroblast growth factor receptor 3 (FGFR3) binding proteinsExpiredJun 30, 09May 29, 12[C07K]
7998973 Tivozanib and temsirolimus in combinationExpiredAug 13, 10Aug 16, 11[A61K, A01N, C07D]
7935502 Hepatocyte growth factor (HGF) binding proteinsExpiredDec 07, 09May 03, 11[C07H, C12P, C12N]
2010/0048,898 Process for Synthesizing 7-Alkynyl-4- Aminoquinazolines and a Related IntermediateAbandonedMar 02, 07Feb 25, 10[C07D]
7622630 Chimeric cancer modelsExpiredAug 27, 04Nov 24, 09[C12N, A01K]
7615353 Tivozanib response predictionExpiredJul 06, 09Nov 10, 09[C07H, C12Q, C12P]
7556796 Directed complementationExpiredApr 05, 06Jul 07, 09[A61K]
2009/0165,150 DIRECTED COMPLEMENTATION WITH REMOVABLE GENE OF INTERESTAbandonedDec 21, 07Jun 25, 09[C12N, A01K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.